Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Syphilis
100%
Prospero
100%
External Quality Assessment
100%
Reference Laboratory
50%
HIV Testing
37%
Clinical Site
37%
Rapid Plasma Reagin
37%
Treponema Pallidum Particle Agglutination Assay
37%
Dried Tube Specimen
37%
Syphilis Testing
37%
HIV Antibodies
25%
Point-of-care Test
25%
Dual Path Platform
25%
Testing Sites
25%
POC Diagnostics
25%
Laboratory-based
12%
Commercially Available
12%
Serological Test
12%
Continuous Monitoring
12%
Infection Point
12%
Public Health Risk
12%
Sexually Transmitted Infections
12%
Locally Available
12%
Expected Outcomes
12%
Bioassay Test
12%
Hereafter
12%
Assessment Performance
12%
Continuous Training
12%
Antibody Detection
12%
CHEMBIO
12%
Clinic-based
12%
Human Immunodeficiency Virus Type 1 (HIV-1)
12%
HIV-2
12%
Point-of-care Testing
12%
Clinical Testing
12%
Testing Errors
12%
OraQuick
12%
Dual Test
12%
Transmitted Infection
12%
Geenius
12%
Percentage Agreement
12%
Concordance Rate
12%
Genetic System
12%
Rapid Point-of-care Test
12%
Nursing and Health Professions
Human Immunodeficiency Virus
100%
Quality Control
100%
Syphilis
100%
World Health Organization
100%
HIV Test
18%
Human Immunodeficiency Virus Antibody
18%
Reaginic Antibody
18%
Serology
9%
Infection
9%
Enzyme Immunoassay
9%
Reagin Test
9%
Hepatitis C Rapid Test
9%
Point of Care Testing
9%
Nutrition Policy
9%
Medicine and Dentistry
Human Immunodeficiency Virus
100%
Syphilis
100%
Treponema Pallidum Particle Agglutination Assay
27%
HIV Test
18%
Rapid Plasma Reagin
18%
Human Immunodeficiency Virus Antibody
18%
Infection
9%
Public Health
9%
Enzyme Immunoassay
9%
Point-of-Care Testing
9%
Reagin Test
9%
Serological Test
9%
Hepatitis C Rapid Test
9%
Sexually Transmitted Infection
9%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Syphilis
100%
Reaginic Antibody
25%
Treponema pallidum
25%
Human Immunodeficiency Virus Antibody
16%
Infection
8%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Blood Plasma
27%
Antigen-Antibody Interaction
27%
Treponema pallidum
27%
Reaginic Antibody
27%
Human Immunodeficiency Virus Antibody
18%
Serology
9%
Human Immunodeficiency Virus 1
9%